Variant report

Variant	esv3421012
Chromosome Location	chr4:48483395-48487593
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:210)
CpG islands
(count:978)
Chromatin interactive
region (count:5)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:210 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:48483723-48484037	K562	blood:	n/a	n/a
2	ARID3A	chr4:48484962-48485247	K562	blood:	n/a	n/a
3	ARID3A	chr4:48487020-48487153	K562	blood:	n/a	n/a
4	ATF1	chr4:48483638-48483988	K562	blood:	n/a	n/a
5	BACH1	chr4:48485777-48486288	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr4:48486855-48487010	H1-hESC	embryonic stem cell:	n/a	n/a
7	BACH1	chr4:48485381-48485382	H1-hESC	embryonic stem cell:	n/a	n/a
8	BHLHE40	chr4:48485470-48485714	K562	blood:	n/a	chr4:48485560-48485576
9	BHLHE40	chr4:48483691-48483965	K562	blood:	n/a	n/a
10	BHLHE40	chr4:48486934-48487121	K562	blood:	n/a	n/a
11	CBX3	chr4:48485746-48486116	K562	blood:	n/a	n/a
12	CBX3	chr4:48483613-48484010	K562	blood:	n/a	n/a
13	CCNT2	chr4:48486352-48486939	K562	blood:	n/a	n/a
14	CCNT2	chr4:48485129-48486088	K562	blood:	n/a	n/a
15	CCNT2	chr4:48483694-48483987	K562	blood:	n/a	n/a
16	CEBPB	chr4:48483480-48483916	K562	blood:	n/a	chr4:48483581-48483594 chr4:48483583-48483594
17	CEBPD	chr4:48483548-48484092	K562	blood:	n/a	n/a
18	CEBPD	chr4:48483530-48484088	K562	blood:	n/a	n/a
19	CHD2	chr4:48486715-48486814	H1-hESC	embryonic stem cell:	n/a	n/a
20	CHD2	chr4:48485558-48485586	K562	blood:	n/a	n/a
21	CHD2	chr4:48483568-48483726	K562	blood:	n/a	n/a
22	CREB1	chr4:48485290-48485607	A549	lung:	n/a	n/a
23	CREB1	chr4:48485358-48485716	H1-hESC	embryonic stem cell:	n/a	n/a
24	CTBP2	chr4:48485327-48486322	H1-hESC	embryonic stem cell:	n/a	n/a
25	CTCF	chr4:48485960-48486110	K562	blood:	n/a	n/a
26	CTCF	chr4:48485900-48486050	SK-N-SH_RA	brain:	n/a	n/a
27	CTCF	chr4:48486140-48486290	BE2_C	brain:	n/a	n/a
28	CTCF	chr4:48485920-48486070	GM12871	blood:	n/a	n/a
29	CTCF	chr4:48485869-48486030	A549	lung:	n/a	n/a
30	CTCF	chr4:48485696-48486186	K562	blood:	n/a	n/a
31	CTCF	chr4:48486000-48486150	GM12869	blood:	n/a	n/a
32	CTCF	chr4:48485920-48486070	GM12867	blood:	n/a	n/a
33	CTCF	chr4:48485940-48486090	AG04449	skin:	n/a	n/a
34	CTCF	chr4:48485880-48486030	K562	blood:	n/a	n/a
35	CTCF	chr4:48485876-48485877	GM19239	blood:	n/a	n/a
36	CTCF	chr4:48485880-48486030	GM12874	blood:	n/a	n/a
37	CTCF	chr4:48484452-48484645	K562	blood:	n/a	chr4:48484482-48484490
38	CTCF	chr4:48485936-48485983	Medullo	brain:	n/a	n/a
39	CTCF	chr4:48486200-48486350	SK-N-SH_RA	brain:	n/a	chr4:48486338-48486346 chr4:48486337-48486345
40	CTCF	chr4:48485878-48486008	GM19239	blood:	n/a	n/a
41	CTCF	chr4:48485860-48486010	BE2_C	brain:	n/a	n/a
42	CTCF	chr4:48485882-48486279	K562	blood:	n/a	n/a
43	CTCF	chr4:48485933-48485975	NHEK	skin:	n/a	n/a
44	CTCF	chr4:48486260-48486283	GM20000	blood:	n/a	n/a
45	CTCF	chr4:48485890-48486021	H1-hESC	embryonic stem cell:	n/a	n/a
46	CTCF	chr4:48485774-48486108	K562	blood:	n/a	n/a
47	CTCF	chr4:48485880-48486030	HUVEC	blood vessel:	n/a	n/a
48	CTCF	chr4:48485843-48486023	Fibrobl	skin:	n/a	n/a
49	CTCF	chr4:48484560-48484710	SK-N-SH_RA	brain:	n/a	n/a
50	CTCF	chr4:48484440-48484590	BE2_C	brain:	n/a	chr4:48484482-48484490

(count:978 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:48484788-48484838	HL-60	blood:	n/a
2	chr4:48485306-48485356	AG04450	lung:	fetal
3	chr4:48484788-48484838	HL-60	blood:	n/a
4	chr4:48485306-48485356	AG04450	lung:	fetal
5	chr4:48485624-48485674	HCM	heart:	n/a
6	chr4:48484997-48485047	HRE	kidney:	n/a
7	chr4:48485090-48485140	HAEpiC	amniotic membrane:	n/a
8	chr4:48485233-48485283	HepG2	liver:	n/a
9	chr4:48484997-48485047	ProgFib	skin:	n/a
10	chr4:48485306-48485356	HEK293	kidney:	embryo
11	chr4:48486472-48486522	HL-60	blood:	n/a
12	chr4:48485301-48485351	NHBE	bronchial:	n/a
13	chr4:48486316-48486366	NH-A	brain:	n/a
14	chr4:48485569-48485619	HCM	heart:	n/a
15	chr4:48484788-48484838	HCT-116	colon:	n/a
16	chr4:48484997-48485047	AG09309	skin:	n/a
17	chr4:48485233-48485283	NHBE	bronchial:	n/a
18	chr4:48485301-48485351	AoSMC	blood vessel:	n/a
19	chr4:48484997-48485047	NHDF-neo	bronchial:	n/a
20	chr4:48486472-48486522	A549	lung:	n/a
21	chr4:48485301-48485351	GM12891	blood:	n/a
22	chr4:48484997-48485047	CMK	blood:	n/a
23	chr4:48485233-48485283	GM12878	blood:	n/a
24	chr4:48484788-48484838	HNPCEpiC	eye:	n/a
25	chr4:48485306-48485356	NT2-D1	testis:	n/a
26	chr4:48485306-48485356	HCM	heart:	n/a
27	chr4:48485293-48485343	HCM	heart:	n/a
28	chr4:48486154-48486204	U87	brain:	n/a
29	chr4:48484788-48484838	RPTEC	kidney:	n/a
30	chr4:48486785-48486835	H1-hESC	embryonic stem cell:	embryo
31	chr4:48486087-48486137	Jurkat	blood:	n/a
32	chr4:48485306-48485356	NHBE	bronchial:	n/a
33	chr4:48486087-48486137	Hepatocyte	liver:	n/a
34	chr4:48485301-48485351	GM12878	blood:	n/a
35	chr4:48486472-48486522	GM06990	blood:	n/a
36	chr4:48485301-48485351	A549	lung:	n/a
37	chr4:48485233-48485283	HEEpiC	esophagus:	n/a
38	chr4:48485293-48485343	HRPEpiC	eye:	n/a
39	chr4:48485328-48485378	HAEpiC	amniotic membrane:	n/a
40	chr4:48485293-48485343	Jurkat	blood:	n/a
41	chr4:48485293-48485343	AG10803	skin:	n/a
42	chr4:48486785-48486835	CMK	blood:	n/a
43	chr4:48485289-48485339	HUVEC	blood vessel:	n/a
44	chr4:48485289-48485339	Hela-S3	cervix:	n/a
45	chr4:48485233-48485283	SK-N-SH	brain:	n/a
46	chr4:48485293-48485343	GM12878	blood:	n/a
47	chr4:48485569-48485619	NHBE	bronchial:	n/a
48	chr4:48485569-48485619	ProgFib	skin:	n/a
49	chr4:48486087-48486137	Caco-2	colon:	n/a
50	chr4:48485624-48485674	Hepatocyte	liver:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:48474711..48478093-chr4:48481760..48484353,3	K562	blood:
2	chr4:48478979..48481680-chr4:48482843..48484535,2	K562	blood:
3	chr4:48341909..48343469-chr4:48483589..48486077,2	K562	blood:
4	chr4:48485954..48488857-chr4:48528912..48531083,2	K562	blood:
5	chr4:48484114..48487251-chr4:48504187..48509460,5	K562	blood:

No data

Variant related genes	Relation type
SLC10A4	TF binding region
ZAR1	TF binding region
SLC10A4	CpG island
ZAR1	CpG island
ENSG00000075539	chromatin interactions
ENSG00000109171	chromatin interactions

Extended variants
information (count: 124 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:124 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs114846253	chr4:48483403-48483404	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs6447640	chr4:48483416-48483417	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
3	rs192807572	chr4:48483447-48483448	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs569823977	chr4:48483475-48483476	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs537100417	chr4:48483578-48483579	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs535817696	chr4:48483598-48483599	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs573764250	chr4:48483608-48483609	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs375842342	chr4:48483647-48483648	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs369948537	chr4:48483751-48483752	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs373166857	chr4:48483761-48483762	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs547812528	chr4:48483874-48483875	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs183710360	chr4:48483889-48483890	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs577974319	chr4:48483912-48483913	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs56190922	chr4:48483913-48483914	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs7697851	chr4:48483930-48483931	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs563229868	chr4:48483943-48483944	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs114977824	chr4:48483995-48483996	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs145624100	chr4:48484014-48484015	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs200458408	chr4:48484018-48484019	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs369299363	chr4:48484045-48484046	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs534266538	chr4:48484055-48484056	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs6812980	chr4:48484060-48484061	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs529465127	chr4:48484098-48484099	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs547646647	chr4:48484117-48484118	Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs77814600	chr4:48484138-48484139	Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs533404837	chr4:48484210-48484211	Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs551362899	chr4:48484259-48484260	Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs34386102	chr4:48484266-48484267	Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs188538012	chr4:48484379-48484380	Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs34447823	chr4:48484412-48484413	Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs549435802	chr4:48484479-48484480	Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs370123413	chr4:48484485-48484486	Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs193250634	chr4:48484493-48484494	Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs534835297	chr4:48484498-48484499	Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs185026142	chr4:48484642-48484643	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs188229874	chr4:48484655-48484656	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs200217312	chr4:48484672-48484673	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs578002861	chr4:48484802-48484803	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs376650916	chr4:48484864-48484865	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs556352087	chr4:48484867-48484868	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs13125511	chr4:48484887-48484888	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs148894767	chr4:48485041-48485042	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs6836632	chr4:48485075-48485076	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs561057455	chr4:48485157-48485158	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs572815120	chr4:48485162-48485163	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs145545926	chr4:48485167-48485168	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs559472054	chr4:48485169-48485170	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs533492073	chr4:48485233-48485234	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs386674318	chr4:48485248-48485249	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs35118024	chr4:48485250-48485251	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
Oral squamous cell carcinoma	17134496	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Cancer	22183965	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Basal cell lymphoma	21115979	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
small cell lung cancer	20016488	CNVD

Chromatin state (count:293 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:48473000-48483600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr4:48479800-48484200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
3	chr4:48480000-48483400	Weak transcription	K562	blood
4	chr4:48480000-48484000	Weak transcription	Cortex derived primary cultured neurospheres	brain
5	chr4:48483400-48484600	Enhancers	K562	blood
6	chr4:48483600-48484400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
7	chr4:48483800-48484000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr4:48484000-48484800	Enhancers	Cortex derived primary cultured neurospheres	brain
9	chr4:48484200-48484600	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
10	chr4:48484200-48484600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
11	chr4:48484200-48484800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
12	chr4:48484400-48484600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
13	chr4:48484400-48484600	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
14	chr4:48484400-48484800	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr4:48484400-48484800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
16	chr4:48484400-48484800	Enhancers	A549	lung
17	chr4:48484600-48484800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
18	chr4:48484600-48484800	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
19	chr4:48484600-48485000	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
20	chr4:48484600-48485000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
21	chr4:48484600-48485000	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
22	chr4:48484600-48485000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
23	chr4:48484600-48485000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
24	chr4:48484600-48485200	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
25	chr4:48484600-48485200	Flanking Active TSS	K562	blood
26	chr4:48484600-48486600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
27	chr4:48484600-48486600	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
28	chr4:48484800-48485000	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
29	chr4:48484800-48485000	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
30	chr4:48484800-48485000	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
31	chr4:48484800-48485000	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
32	chr4:48484800-48485000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
33	chr4:48484800-48485000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
34	chr4:48484800-48485000	Enhancers	Brain Substantia Nigra	brain
35	chr4:48484800-48485000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
36	chr4:48484800-48485000	Bivalent Enhancer	Fetal Intestine Small	intestine
37	chr4:48484800-48485200	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
38	chr4:48484800-48485200	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
39	chr4:48484800-48485200	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
40	chr4:48484800-48485200	Bivalent Enhancer	Fetal Brain Male	brain
41	chr4:48484800-48485200	Bivalent Enhancer	Fetal Heart	heart
42	chr4:48484800-48485800	Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
43	chr4:48484800-48485800	Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr4:48484800-48486000	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr4:48484800-48486000	Bivalent/Poised TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
46	chr4:48484800-48486200	Bivalent/Poised TSS	Brain Germinal Matrix	brain
47	chr4:48484800-48486600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
48	chr4:48484800-48487200	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
49	chr4:48484800-48487200	Active TSS	A549	lung
50	chr4:48485000-48485200	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links